Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
77.24
-2.09 (-2.63%)
Sep 18, 2026, 4:00 PM EDT - Market closed
KNSA Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 80.66 | 59.01 | -43.19 | 14.08 | 183.36 | -157.92 |
Depreciation & Amortization | 1.79 | 1.55 | 1.7 | 2.34 | 2.4 | 2.36 |
Loss (Gain) From Sale of Assets | -0.13 | -0.12 | -0.02 | 0.18 | 0.03 | 0.1 |
Loss (Gain) From Sale of Investments | 1.07 | -0.92 | 0.44 | -1.07 | -0.08 | 0.66 |
Stock-Based Compensation | 42.07 | 37 | 30.69 | 27.15 | 25.12 | 25.17 |
Other Operating Activities | 18.46 | 16.67 | 11.27 | -30.73 | -182.45 | 2.64 |
Change in Accounts Receivable | 8.42 | 26.13 | -20.46 | -0.95 | -16.33 | -3.91 |
Change in Inventory | -22.75 | -28.53 | 4.76 | -9.52 | -17.92 | -3.68 |
Change in Accounts Payable | 3.42 | 0.14 | -6.31 | 0.35 | 6.03 | 1.37 |
Change in Unearned Revenue | - | - | 19.55 | 0.26 | 12 | - |
Change in Other Net Operating Assets | 51.96 | 27.05 | 27.27 | 11.22 | -6.35 | 6.91 |
Operating Cash Flow | 184.97 | 137.99 | 25.69 | 13.3 | 5.81 | -126.3 |
Operating Cash Flow Growth | 176.28% | 437.14% | 93.14% | 129.05% | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -2.13 | -1.57 | -0.28 | -0.13 | -0.11 | -0.42 |
Sale of Property, Plant & Equipment | - | - | 0.03 | - | 0.09 | - |
Sale (Purchase) of Intangibles | - | - | - | - | - | -20 |
Investment in Securities | -236.94 | -187.43 | 37.92 | -29.43 | -8.06 | 149.05 |
Investing Cash Flow | -239.07 | -188.99 | 37.67 | -29.56 | -8.08 | 128.64 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | 48.8 | 40.75 | 17.25 | 3.7 | 3.42 | 5.89 |
Repurchase of Common Stock | -11.06 | -7.73 | -4.98 | -2.21 | -0.9 | - |
Financing Cash Flow | 37.74 | 33.02 | 12.27 | 1.5 | 2.52 | 5.89 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -16.36 | -17.99 | 75.63 | -14.76 | 0.25 | 8.22 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 182.84 | 136.42 | 25.41 | 13.17 | 5.7 | -126.71 |
Free Cash Flow Growth | 174.98% | 436.82% | 92.94% | 130.99% | - | - |
Free Cash Flow Margin | 21.74% | 20.13% | 6.00% | 4.87% | 2.59% | -328.75% |
Free Cash Flow Per Share | 2.23 | 1.73 | 0.36 | 0.18 | 0.08 | -1.85 |
Levered Free Cash Flow | 126.14 | 97.89 | 22.57 | 13.79 | -2.36 | -83.56 |
Unlevered Free Cash Flow | 126.14 | 97.89 | 22.57 | 13.79 | -2.36 | -83.56 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 0.01 | 3.01 | 2 | 5.61 | 10.69 | 1.28 |
Change in Working Capital | 41.04 | 24.79 | 24.81 | 1.35 | -22.58 | 0.69 |